Zhongda'an: Wu Junye, the controlling shareholder, plans to reduce his holdings by no more than 2%

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

Momenta says it is first Chinese company with Germany-wide L4 testing permit

Momenta Global Limited（Momenta，初速度科技）said on July 29 that it had received authorization from Germany’s Federal Motor Transport Authority, or KBA, to test Level 4 autonomous-driving systems on urban roads across the country. The Hong Kong-listed company said it was the first Chinese enterprise to obtain a German L4 testing permit with nationwide urban-road coverage.

XPeng’s estimated overseas deliveries pass 100,000 as global expansion accelerates

XPeng（小鹏汽车） appears to have surpassed 100,000 cumulative vehicle deliveries in overseas markets, based on company disclosures and publicly available shipment and registration data. The Chinese smart-electric-vehicle maker has not announced an official cumulative overseas total, making the figure an estimate rather than a company-confirmed milestone.

Baidu’s Apollo Go Begins Supervised Road Testing in London with Freenow by Lyft

Baidu, Inc.（百度）has begun testing its Apollo Go（萝卜快跑）autonomous vehicles on public roads in London with Freenow by Lyft, marking the Chinese company’s first road deployment in the British capital.

BYD Launches Japan-Specific RACCO Electric Kei Car, Starting at JPY 2.15 Million

BYD has begun selling its first electric kei car developed specifically for Japan, entering a vehicle category that accounts for more than one-third of new-car sales in the country.